Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function

Journal of Neuroscience

Volumn 30, Issue 40, 2010, Pages 13409-13418

  Peethumnongsin, Erica ^a   Yang, Li ^a   Kallhoff Muñoz, Verena ^a   Hu, Lingyun ^a   Takashima, Akihiko ^b   Pautler, Robia G ^a   Zheng, Hui ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NEUROTROPHIN; PRESENILIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; KNOCKOUT MOUSE; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPTUM NUCLEUS; SIGNAL TRANSDUCTION; WILD TYPE;

ALZHEIMER DISEASE; ANIMALS; AXONAL TRANSPORT; AXONS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONAL PLASTICITY; NEURONS; ORGAN CULTURE TECHNIQUES; PRESENILIN-1; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TAU PROTEINS;

EID: 77957742204     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1964-10.2010     Document Type: Article

References (52)

1. Akins MR, Greer CA (2006) Cytoskeletal organization of the developing mouse olfactory nerve layer. J Comp Neurol 494:358-367.
2. Burnett KR, Goldstein EJ, Wolf GL, Sen S, Mamourian AC (1984) The oral administration of MnCl2: a potential alternative to IV injection for tissue contrast enhancement in magnetic resonance imaging. Magn Reson Imaging 2:307-314.
3. Caleo M, Cenni MC (2004) Anterograde transport of neurotrophic factors: possible therapeutic implications. Mol Neurobiol 29:179-196.
4. Chen F, Gu Y, Hasegawa H, Ruan X, Arawaka S, Fraser P, Westaway D, Mount H, St George-Hyslop P (2002) Presenilin 1 mutations activate gamma 42-secretase but reciprocally inhibit epsilon-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch. J Biol Chem 277:36521-36526.
5. Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP (2008) Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. J Neurosci Res 86:1615-1625. (Pubitemid 351642455)
6. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313. (Pubitemid 27137397)
7. Cory DA, Schwartzentruber DJ, Mock BH (1987) Ingested manganese chloride as a contrast agent for magnetic resonance imaging. Magn Reson Imaging 5:65-70. (Pubitemid 17059060)
8. Cross DJ, Flexman JA, Anzai Y, Maravilla KR, Minoshima S (2008) Age-related decrease in axonal transport measured by MR imaging in vivo. Neuroimage 39:915-926.
9. De Strooper B (2007) Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8:141-146.
10. Dobrunz LE, Stevens CF (1997) Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 18:995-1008.
11. Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, Bernstein A (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 13:2801-2810.
12. Feng R, Rampon C, Tang YP, Shrom D, Jin J, Kyin M, Sopher B, Miller MW, Ware CB, Martin GM, Kim SH, Langdon RB, Sisodia SS, Tsien JZ (2001) Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32:911-926. (Pubitemid 34024850)
13. Feng R, Wang H, Wang J, Shrom D, Zeng X, Tsien JZ (2004) Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. Proc Natl Acad Sci U S A 101:8162-8167. (Pubitemid 38698071)
14. Fornasiero D, Bellen JC, Baker RJ, Chatterton BE (1987) Paramagnetic complexes of manganese(II), iron(III), and gadolinium(III) as contrast agents for magnetic resonance imaging. The influence of stability constants on the biodistribution of radioactive aminopolycarboxylate complexes. Invest Radiol 22:322-327.
15. Gauthier LR, Charrin BC, Borrell-Pagès M, Dompierre JP, Rangone H, Cordelières FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127-138. (Pubitemid 38902819)
16. 2+ complexes of various polyaza macrocyclic ligands: implications for NMR imaging. Magn Reson Med 3:242-250.
17. Higuchi M, Lee VM, Trojanowski JQ (2002) Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2:131-150.
18. Ittner LM, Fath T, Ke YD, Bi M, van Eersel J, Li KM, Gunning P, Götz J (2008) Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc Natl Acad Sci U S A 105:15997-16002.
19. Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391. (Pubitemid 30389307)
20. Kása P, Rakonczay Z, Gulya K (1997) The cholinergic system in Alzheimer's disease. Prog Neurobiol 52:511-535.
21. Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N, Takashima A (2007) Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau. EMBO J 26:5143-5152. (Pubitemid 350261280)
22. Kotani S, Yamauchi T, Teramoto T, Ogura H (2006) Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 142:505-514. (Pubitemid 44415335)
23. LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, Brady ST (2009) The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J Neurosci Res 87:440-451.
24. Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, Robinson J, Ho H, Brady ST, Sisodia SS (2007) Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 27:7011-7020. (Pubitemid 47015908)
25. Mattson MP (2010) ER calcium and Alzheimer's disease: in a state of flux. Sci Signal 3:pe10.
26. Mendonça-Dias MH, Gaggelli E, Lauterbur PC (1983) Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 13:364-376.
27. Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 55:84-90. (Pubitemid 28139109)
28. Mi K, Johnson GV (2006) The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 3:449-463. (Pubitemid 46070114)
29. Minoshima S, Cross D (2008) In vivo imaging of axonal transport using MRI: aging and Alzheimer's disease. Eur J Nucl Med Mol Imaging 35 [Suppl 1]:S89-S92.
30. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C, Steiner H (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A 99:8025-8030. (Pubitemid 34650999)
31. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21:281-293. (Pubitemid 34137290)
32. Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63:71-124.
33. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15:331-337.
34. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T, Qian X, Ginty DD, Price DL, Borchelt DR, Wong PC, Sisodia SS (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21:1213-1221. (Pubitemid 29018089)
35. Parent MB, Baxter MG (2004) Septohippocampal acetylcholine: involved in but not necessary for learning and memory? Learn Mem 11:9-20.
36. Parks AL, Curtis D (2007) Presenilin diversifies its portfolio. Trends Genet 23:140-150.
37. Peters JM, Hummel T, Kratzsch T, Lötsch J, Skarke C, Frölich L (2003) Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 160:1995-2002. (Pubitemid 39619637)
38. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J (2003) Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 23:4499-4508. (Pubitemid 36706180)
39. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE (2003) Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A 100:1381-1386. (Pubitemid 36184010)
40. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, Chattarji S, Kelleher RJ 3rd, Kandel ER, Duff K, Kirkwood A, Shen J (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42:23-36. (Pubitemid 38456965)
41. Schindowski K, Belarbi K, Buée L (2008) Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 7 [Suppl 1]:43-56.
42. Seltzer B (2006) Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. J Int Med Res 34:339-347.
43. Shen J, Kelleher RJ 3rd (2007) The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A 104:403-409. (Pubitemid 46123039)
44. Sloot WN, Gramsbergen JB (1994) Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 657:124-132.
45. Smith KD, Kallhoff V, Zheng H, Pautler RG (2007) In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 35:1401-1408.
46. Spencer CM, Serysheva E, Yuva-Paylor LA, Oostra BA, Nelson DL, Paylor R (2006) Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Hum Mol Genet 15:1984-1994. (Pubitemid 43983272)
47. Tindemans I, Verhoye M, Balthazart J, Van Der Linden A (2003) In vivo dynamic ME-MRI reveals differential functional responses of RA- and area X-projecting neurons in the HVC of canaries exposed to conspecific song. Eur J Neurosci 18:3352-3360.
48. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER, Tonegawa S (1996) Subregion-and cell type-restricted gene knockout in mouse brain [see comments]. Cell 87:1317-1326. (Pubitemid 27010114)
49. Wiley JC, Hudson M, Kanning KC, Schecterson LC, Bothwell M (2005) Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. J Neurochem 94:1189-1201. (Pubitemid 41232575)
50. Ying SW, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TV, Bramham CR (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22:1532-1540. (Pubitemid 35386272)
51. Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, Martinez D, Joyce S, Trojanowski JQ, Lee VM (2004) Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J Neurosci 24:4657-4667. (Pubitemid 38656621)
52. Zhang C, Wu B, Beglopolous V, Wines-Samuelson M, Zhang D, Dragatsis I, Sudhof TC, Shen J (2009) Presenilins are essential for regulating neurotransmitter release. Nature 460:632-636.